Johannes Betge

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Nature communications

Signal transduction and targeted therapy

NPJ genomic medicine

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes Betge, Matthias P Ebert
Unveiling the culprit: the fusobacterium lineage that populates colorectal cancer. Signal transduction and targeted therapy 9 (1) (2024)
Johannes Betge, Matthias P Ebert
Unveiling the culprit: the fusobacterium lineage that populates colorectal cancer. Signal transduction and targeted therapy 9 (1) (2024)
Michael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, David Vonhören, Selina Jansky, Julius Michel, Anna Keib, Saskia Stange, Nicolaj S Hackert, Niklas Kehl, Markus Hahn, Antje Habel, Stefanie Jung, Kristine Jähne, Felix Sahm, Johannes Betge, Adelheid Cerwenka, Frank Westermann, Peter Dreger, Marc-Steffen Raab, Nadja M Meindl-Beinker, Matthias P A Ebert, Lukas Bunse, Carsten Müller-Tidow, Michael Schmitt, Michael Platten
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance. Science immunology 9 (95) (2024)
Johannes Betge, Matthias P Ebert
Unveiling the culprit: the fusobacterium lineage that populates colorectal cancer. Signal transduction and targeted therapy 9 (1) (2024)
Tom Venken, Ian S Miller, Ingrid Arijs, Valentina Thomas, Ana Barat, Johannes Betge, Tianzuo Zhan, Timo Gaiser, Matthias P Ebert, Alice C O'Farrell, Jochen Prehn, Rut Klinger, Darran P O'Connor, Brian Moulton, Verena Murphy, Garazi Serna, Paolo G Nuciforo, Ray McDermott, Brian Bird, Gregory Leonard, Liam Grogan, Anne Horgan, Nadine Schulte, Markus Moehler, Diether Lambrechts, Anthony L Byrne
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients. NPJ genomic medicine 9 (1) (2024)
Michael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, David Vonhören, Selina Jansky, Julius Michel, Anna Keib, Saskia Stange, Nicolaj S Hackert, Niklas Kehl, Markus Hahn, Antje Habel, Stefanie Jung, Kristine Jähne, Felix Sahm, Johannes Betge, Adelheid Cerwenka, Frank Westermann, Peter Dreger, Marc-Steffen Raab, Nadja M Meindl-Beinker, Matthias P A Ebert, Lukas Bunse, Carsten Müller-Tidow, Michael Schmitt, Michael Platten
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance. Science immunology 9 (95) (2024)
Tom Venken, Ian S Miller, Ingrid Arijs, Valentina Thomas, Ana Barat, Johannes Betge, Tianzuo Zhan, Timo Gaiser, Matthias P Ebert, Alice C O'Farrell, Jochen Prehn, Rut Klinger, Darran P O'Connor, Brian Moulton, Verena Murphy, Garazi Serna, Paolo G Nuciforo, Ray McDermott, Brian Bird, Gregory Leonard, Liam Grogan, Anne Horgan, Nadine Schulte, Markus Moehler, Diether Lambrechts, Anthony L Byrne
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients. NPJ genomic medicine 9 (1) (2024)
Hichul Kim, Victoria El-Khoury, Nadine Schulte, Tianzuo Zhan, Johannes Betge, Loic Cousin, Emanuele Felli, Patrick Pessaux, Arnaud Ogier, Oliver Opitz, Bosung Ku, Matthias P Ebert, Yong-Jun Kwon
Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid. Cancer biology & therapy 23 (1) (2022)
Johannes Betge, Niklas Rindtorff, Jan Sauer, Benedikt Rauscher, Clara Dingert, Haristi Gaitantzi, Frank Herweck, Kauthar Srour-Mhanna, Thilo Miersch, Erica Valentini, Kim E Boonekamp, Veronika Hauber, Tobias Gutting, Larissa Frank, Sebastian Belle, Timo Gaiser, Inga Buchholz, Ralf Jesenofsky, Nicolai Härtel, Tianzuo Zhan, Bernd Fischer, Katja Breitkopf-Heinlein, Elke Burgermeister, Matthias P A Ebert, Michael Boutros
The drug-induced phenotypic landscape of colorectal cancer organoids. Nature communications 13 (1) (2022)
Johannes Betge, Rene Jackstadt
From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer. International journal of cancer (2022)
Julian E Riedesser, Matthias P Ebert, Johannes Betge
Precision medicine for metastatic colorectal cancer in clinical practice. Therapeutic advances in medical oncology 14 (2022)
Christopher Fabian Maier, Lei Zhu, Lahiri Kanth Nanduri, Daniel Kühn, Susan Kochall, May-Linn Thepkaysone, Doreen William, Konrad Grützmann, Barbara Klink, Johannes Betge, Jürgen Weitz, Nuh N Rahbari, Christoph Reissfelder, Sebastian Schölch
Patient-Derived Organoids of Cholangiocarcinoma. International journal of molecular sciences 22 (16) (2021)
Adam Lafferty, Alice C O'Farrell, Giorgia Migliardi, Niraj Khemka, Andreas U Lindner, Francesco Sassi, Eugenia R Zanella, Manuela Salvucci, Evy Vanderheyden, Elodie Modave, Bram Boeckx, Luise Halang, Johannes Betge, Matthias P A Ebert, Patrick Dicker, Guillem Argilés, Josep Tabernero, Rodrigo Dienstmann, Enzo Medico, Diether Lambrechts, Andrea Bertotti, Claudio Isella, Livio Trusolino, Jochen H M Prehn, Anthony L Byrne
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Ana Barat, Dominiek Smeets, Bruce Moran, Wu Zhang, Shu Cao, Sudipto Das, Rut Klinger, Johannes Betge, Verena Murphy, Orna Bacon, Elaine W Kay, Nicole C T van Grieken, Henk M W Verheul, Timo Gaiser, Nadine Schulte, Matthias P Ebert, Bozena Fender, Bryan T Hennessy, Deborah A McNamara, Darran O'Connor, William M Gallagher, Chiara Cremolini, Fotios Loupakis, Aparna Parikh, Christoph Mancao, Bauke Ylstra, Diether Lambrechts, Heinz-Josef Lenz, Annette T Byrne, Jochen H M Prehn
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer. Scientific reports 10 (1) (2020)
Tianzuo Zhan, Giulia Ambrosi, Anna Maxi Wandmacher, Benedikt Rauscher, Johannes Betge, Niklas Rindtorff, Ragna S Häussler, Isabel Hinsenkamp, Leonhard Bamberg, Bernd Hessling, Karin Müller-Decker, Gerrit Erdmann, Elke Burgermeister, Matthias P Ebert, Michael Boutros
MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nature communications 10 (1) (2019)
Johannes Betge, Jing Chi-Kern, Nadine Schulte, Sebastian Belle, Tobias Gutting, Elke Burgermeister, Ralf Jesenofsky, Martin Maenz, Ulrich Wedding, Matthias P Ebert, Nicolai Haertel
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax). BMC cancer 18 (1) (2018)
Dominiek Smeets, Ian S Miller, Aisling E O'Connor, Sudipto Das, Bruce Moran, Bram Boeckx, Timo Gaiser, Johannes Betge, Ana Barat, Rut Klinger, Nicole C T van Grieken, Chiara Cremolini, Hans Prenen, Massimiliano Mazzone, Jeroen Depreeuw, Orna Bacon, Bozena Fender, Joseph Brady, Bryan T Hennessy, Deborah A McNamara, Elaine Kay, Henk M Verheul, Neerincx Maarten, William M Gallagher, Verena Murphy, Jochen H M Prehn, Miriam Koopman, Cornelis J A Punt, Fotios Loupakis, Matthias P A Ebert, Bauke Ylstra, Diether Lambrechts, Annette T Byrne
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy. Nature communications 9 (1) (2018)

Johannes Betge.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Johannes Betge